Get Started

AXSM

NASD Axsome Therapeutics, Inc.
Oct 30, 2026 · 9:34 PM ET EOD Market Closed

$144.43 ↑ +0.00 (+0.00%) Trading Up from the previous close of $144.43, $1.73 below the day’s high of $146.17

YTD change
-20.92%
vs 20-day SMA
-9.49%
vs 200-day SMA
-27.60%

Price ranges

Previous day
$140.42 $147.49
open $146.79 close $143.45
-$3.34 (-2.28%)
Today
$131.27 $146.17
open $143.23 now $144.43
+$1.20 (+0.84%)
Past week
$140.42 $156.07
from $156.07 now $144.43
-$11.64 (-7.46%)
Past month
$140.42 $182.55
from $182.07 now $144.43
-$37.64 (-20.67%)
This year
$131.27 $260.19
from $182.64 now $144.43
-$38.21 (-20.92%)

Price & Performance

-63.32 (-30.48%) / 6M

$133.16$176.84$220.53$264.21Apr 30Jul 31Oct 30

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Not So Good
  • The stock is 44.5% away from all-time highs of $260.19
  • AXSM is down 21% since the beginning of the year
  • AXSM is up 8% over the past 12 months
  • AXSM is down 21% over the past 1 month
  • 7% of all AXSM investors are betting against AXSM

AXSM reads not so good: price sits below both the 20- and 200-day averages, the 12-month move is +8.5%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.99
Earnings momentum -56.1% Quarterly EPS growth
Quarterly change -56.1%

Valuation

P/E ratio N/A
Enterprise value $7.3B
Beta 1.12

Balance sheet & scale

IncomeN/A
Revenue$776.6M
Cash$319.9M
Debt$224.7K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $7.6B

Axsome Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which engages in the development of novel therapies for the management of central nervous system disorders. Its portfolio consists of Products Overview and Pipeline Overview. The Products Overview includes Auvelity and Sunosi. The Pipeline Overview refers to AXS-05, AXS-07, AXS-12, and AXS-14. The company was founded by Herriot Tabuteau on January 12, 2012 and is headquartered in New York, NY.

Competitor comparison

TickerCompany PriceChange
AMGN Amgen Inc. $466.01 +1.15%
MRNA Moderna, Inc. $221.72 -0.47%
RVMD Revolution Medicines, Inc. $191.31 +0.55%
ROIV Roivant Sciences Ltd. $36.91 -1.63%
BNTX BioNTech SE Sponsored ADR $88.17 -1.08%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.